Synthesis of thiolated, PEGylated and POZylated silica nanoparticles and evaluation of their retention on rat intestinal mucosa in vitro

Eur J Pharm Sci. 2018 Sep 15:122:230-238. doi: 10.1016/j.ejps.2018.06.032. Epub 2018 Jun 30.

Abstract

In this study, we synthesised thiolated silica nanoparticles using 3-mercaptopropyltrimethoxysilane and functionalised them with either 5 kDa methoxy polyethylene glycol maleimide (PEG) or 5 kDa alkyne-terminated poly(2-ethyl-2-oxazoline) (POZ). The main objectives of this study are to investigate the effects of pH on the size and ξ-potential of these nanoparticles and evaluate their mucoadhesive properties ex vivo using rat intestinal mucosa. The sizes of thiolated, PEGylated and POZylated silica nanoparticles were 53 ± 1, 68 ± 1 and 59 ± 1 nm, respectively. The size of both thiolated and POZylated nanoparticles significantly increased at pH ≤ 2, whereas no size change was observed at pH 2.5-9 for both these two types of nanoparticles. On the other hand, the size of PEGylated nanoparticles did not change over the studied pH range (1.5-9). Moreover, thiolated nanoparticles were more mucoadhesive in the rat small intestine than both PEGylated and POZylated nanoparticles. After 12 cycles of washing (with a total of 20 mL of phosphate buffer solution pH 6.8), a significantly greater amount of thiolated nanoparticles remained on the intestinal mucosa than FITC-dextran (non-mucoadhesive polymer, p < 0.005) and both PEGylated and POZylated nanoparticles (p < 0.05 both). However, both PEGylated and POZylated nanoparticles showed similar retention to FITC-dextran (p > 0.1 for both). Thus, this study indicates that thiolated nanoparticles are mucoadhesive, whereas PEGylated and POZylated nanoparticles are non-mucoadhesive in the ex vivo rat intestinal mucosa model. Each of these nanoparticles has potential applications in mucosal drug delivery.

Keywords: Fluorescence; Mucoadhesion; PEGylation; POZylation; Rat; Thiolated.

MeSH terms

  • Adhesiveness
  • Animals
  • Female
  • Intestinal Mucosa / metabolism*
  • Nanoparticles / administration & dosage*
  • Nanoparticles / chemistry
  • Organosilicon Compounds
  • Polyamines / administration & dosage*
  • Polyamines / chemistry
  • Polyethylene Glycols / administration & dosage*
  • Polyethylene Glycols / chemistry
  • Rats, Sprague-Dawley
  • Silanes / administration & dosage*
  • Silanes / chemistry
  • Silicon Dioxide / administration & dosage*
  • Silicon Dioxide / chemistry
  • Silicon Dioxide / pharmacokinetics
  • Sulfhydryl Compounds / administration & dosage*
  • Sulfhydryl Compounds / chemistry

Substances

  • Organosilicon Compounds
  • Polyamines
  • Silanes
  • Sulfhydryl Compounds
  • poly(2-ethyl-2-oxazoline)
  • Polyethylene Glycols
  • Silicon Dioxide
  • (3-mercaptopropyl)trimethoxysilane